miRNA in hepatocellular carcinoma (Q38231531)

31 August 2017

miRNA in hepatocellular carcinoma (English)

1 reference

31 August 2017

Asahiro Morishita

1

1 reference

PubMed ID

25040738

31 August 2017

Tsutomu Masaki

series ordinal

2

1 reference

31 August 2017

7 July 2014

1 reference

31 August 2017

1 reference

31 August 2017

45

1 reference

31 August 2017

2

1 reference

31 August 2017

128-141

1 reference

Ribo-gnome: the big world of small RNAs

31 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Epigenetic alteration and microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNAs in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Combinatorial microRNA target predictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Expression profiling identifies microRNA signature in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNAs in liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Biogenesis of small RNAs in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

The Microprocessor complex mediates the genesis of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

A high-resolution structure of the pre-microRNA nuclear export machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

A human snoRNA with microRNA-like functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Filtering of deep sequencing data reveals the existence of abundant Dicer-dependent small RNAs derived from tRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Intronic microRNA precursors that bypass Drosha processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

A microRNA DNA methylation signature for human cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

A microRNA component of the p53 tumour suppressor network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Rapid alteration of microRNA levels by histone deacetylase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Extensive post-transcriptional regulation of microRNAs and its implications for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

The expression profile of microRNAs in mouse embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MYC protein inhibits transcription of the microRNA cluster MC-let-7a-1~let-7d via noncanonical E-box

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Surrogate alcohols and their metabolites modify histone H3 acetylation: involvement of histone acetyl transferase and histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Epidemiology of viral hepatitis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Role of microRNAs in hepatitis B virus replication and pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA expression, survival, and response to interferon in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Sequencing and bioinformatics-based analyses of the microRNA transcriptome in hepatitis B-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Association study of genetic variations in microRNAs with the risk of hepatitis B-related liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-analysis of 15 case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Let-7c microRNA expression and clinical significance in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4-mediated epithelial-mesenchymal transition and adhesion in hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a/miR-16-1 in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

The Putative PAX8/PPARγ Fusion Oncoprotein Exhibits Partial Tumor Suppressor Activity through Up-Regulation of Micro-RNA-122 and Dominant-Negative PPARγ Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

A c-Myc-MicroRNA functional feedback loop affects hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-203 inhibits proliferation of HCC cells by targeting survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-22 promotes HBV-related hepatocellular carcinoma development in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-221 overexpression contributes to liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-301a is a candidate oncogene that targets the homeobox gene Gax in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-373, a new regulator of protein phosphatase 6, functions as an oncogene in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-550a acts as a pro-metastatic gene and directly targets cytoplasmic polyadenylation element-binding protein 4 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-β RII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

miR-221 silencing blocks hepatocellular carcinoma and promotes survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12386

21 January 2018

Identifiers

DOI

10.1111/HEPR.12386

1 reference

31 August 2017

1 reference

PubMed ID

25040738